These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9651866)

  • 1. Preparation and in vitro dissolution profile of dual polymer (Eudragit RS100 and RL100) microparticles of diltiazem hydrochloride.
    Das SK; Das NG
    J Microencapsul; 1998; 15(4):445-52. PubMed ID: 9651866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel biomaterial for transdermal application: in vitro and in vivo characterization.
    Mundada AS; Avari JG
    Drug Deliv; 2011 Aug; 18(6):424-31. PubMed ID: 21554152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers.
    Kadam VD; Gattani SG
    Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel microparticle drug delivery systems based on chitosan and Eudragit® RSPM to enhance diltiazem hydrochloride release property.
    Cetin EO; Gundogdu E; Kirilmaz L
    Pharm Dev Technol; 2012; 17(6):741-6. PubMed ID: 21563988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
    Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and in vitro evaluation of a novel combined multiparticulate delayed-onset sustained-release formulation of diltiazem hydrochloride.
    Chen S; Zhu J; Cheng J
    Pharmazie; 2007 Dec; 62(12):907-13. PubMed ID: 18214341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
    Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
    Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
    Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and in vitro characterization of diltiazem hydrochloride loaded alginate microspheres.
    Sultana Y; Mall S; Maurya DP; Kumar D; Das M
    Pharm Dev Technol; 2009; 14(3):321-31. PubMed ID: 19235550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.
    Nath B; Nath LK; Kumar P
    Acta Pol Pharm; 2011; 68(3):409-15. PubMed ID: 21648196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of microparticles of naproxen with Eudragit RS and talc by spherical crystallization technique.
    Maghsoodi M; Esfahani M
    Pharm Dev Technol; 2009; 14(4):442-50. PubMed ID: 19235551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
    Alhnan MA; Basit AW
    Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physico-chemical evaluation of acetylsalicylic acid-Eudragit RS100 microspheres prepared using a solvent-partition method.
    Vachon MG; Nairn JG
    J Microencapsul; 1995; 12(3):287-305. PubMed ID: 7650593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
    Krishnamachari Y; Madan P; Lin S
    Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi-emulsion solvent diffusion method: effect of variables.
    Devrim B; Canefe K
    Acta Pol Pharm; 2006; 63(6):521-34. PubMed ID: 17438870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
    Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
    Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
    al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
    Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of mixture design for formulation of albumin containing enteric-coated spray-dried microparticles.
    Shastri PN; Ubale RV; D'Souza MJ
    Drug Dev Ind Pharm; 2013 Feb; 39(2):164-75. PubMed ID: 22591196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of microencapsulation using Eudragit RS100 on the hydrolysis kinetics of acetylsalicylic acid.
    Vachon MG; Nairn JG
    J Microencapsul; 1997; 14(3):281-301. PubMed ID: 9147279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.